Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.

Subjects

Subjects :

Humans
Antiemetics pharmacokinetics
Antiemetics adverse effects
Antiemetics therapeutic use
Kidney Failure, Chronic therapy
Kidney Failure, Chronic complications
Renal Dialysis
Ondansetron pharmacokinetics
Ondansetron therapeutic use
Ondansetron adverse effects

Details

Language :

English

ISSN :

1533-3450

Volume :

35

Issue :

8

Database :

MEDLINE

Journal :

Journal of the American Society of Nephrology : JASN

Publication Type :

Academic Journal

Accession number :

38767970

Full Text :

https://doi.org/10.1681/ASN.0000000000000386